Érvényesül eközben Hám pancreas neuroendocrine tumor overall survuval Sámuel Magában foglal Hűségesen
PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar
Pancreatic neuroendocrine tumor - Wikipedia
Time-trend and recurrence analysis of pancreatic neuroendocrine tumors in: Endocrine Connections Volume 8 Issue 7 (2019)
Kaplan–Meier survival curves of 926 neoplasms by the European... | Download Scientific Diagram
Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital - ScienceDirect
Survival curves in patients with pancreatic neuroendocrine tumors... | Download Scientific Diagram
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors | NEJM
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines in: Endocrine-Related Cancer Volume 24 Issue 2 (2017)
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014 | BMC Endocrine Disorders | Full Text
Survival curves in different surgical status subgroup patients with... | Download Scientific Diagram
Frontiers | Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
Death incidence and survival by European Neuroendocrine Tumor Society... | Download Scientific Diagram
Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): New Developments - Endotext - NCBI Bookshelf
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations